ASMB – assembly biosciences, inc. (US:NASDAQ)

News

Assembly Biosciences (ASMB) had its price target raised by Guggenheim from $39.00 to $43.00. They now have a "buy" rating on the stock.
Assembly Biosciences (ASMB) was upgraded by Wall Street Zen from "buy
Assembly Biosciences (ASMB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights [Yahoo! Finance]
Assembly Biosciences: Q4 Earnings Snapshot [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com